A detailed history of Hbw Advisory Services LLC transactions in Amgen Inc stock. As of the latest transaction made, Hbw Advisory Services LLC holds 8,471 shares of AMGN stock, worth $2.36 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
8,471
Previous 9,030 6.19%
Holding current value
$2.36 Million
Previous $2.82 Million 3.26%
% of portfolio
0.44%
Previous 0.51%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$309.38 - $337.38 $172,943 - $188,595
-559 Reduced 6.19%
8,471 $2.73 Million
Q2 2024

Jul 05, 2024

BUY
$262.75 - $319.31 $451,930 - $549,213
1,720 Added 23.53%
9,030 $2.82 Million
Q4 2023

Jan 16, 2024

BUY
$255.7 - $288.46 $20,711 - $23,365
81 Added 1.12%
7,310 $2.11 Million
Q3 2023

Oct 11, 2023

BUY
$218.65 - $271.46 $1.58 Million - $1.96 Million
7,229 New
7,229 $1.94 Million
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $195,872 - $217,972
-849 Closed
0 $0
Q1 2022

Apr 18, 2022

BUY
$219.27 - $242.57 $186,160 - $205,941
849 New
849 $205,000
Q4 2021

Jan 11, 2022

SELL
$198.88 - $227.6 $194,305 - $222,365
-977 Closed
0 $0
Q3 2021

Oct 08, 2021

BUY
$212.27 - $248.7 $15,283 - $17,906
72 Added 7.96%
977 $208,000
Q2 2021

Jul 15, 2021

SELL
$233.58 - $259.14 $6,073 - $6,737
-26 Reduced 2.79%
905 $220,000
Q1 2021

Apr 13, 2021

BUY
$221.91 - $258.6 $12,205 - $14,223
55 Added 6.28%
931 $232,000
Q4 2020

Jan 12, 2021

BUY
$216.38 - $257.67 $189,548 - $225,718
876 New
876 $201,000
Q3 2020

Oct 14, 2020

SELL
$234.65 - $260.95 $261,869 - $291,220
-1,116 Closed
0 $0
Q2 2020

Jul 08, 2020

BUY
$197.81 - $242.74 $220,755 - $270,897
1,116 New
1,116 $263,000
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $277,733 - $368,350
-1,524 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$189.21 - $243.2 $288,356 - $370,636
1,524 New
1,524 $363,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hbw Advisory Services LLC Portfolio

Follow Hbw Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbw Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbw Advisory Services LLC with notifications on news.